Translational immunotherapy - crossing boundaries - Aarhus

This is the fourth Aarhus Immunotherapy Symposiom with local and international experts to present their results and discuss their views on immunotherapy.


29-11-2018 13:00 - 16:30


Vennelyst Boulevard 4
8000 C - Aarhus C


Department of Biomedicine, Aarhus University


This year, the symposium addresses T cell and B cell immunity, methods to modulate autoimmunity and allergy, abiomarkers to monitor and predict the severity of disease, and the likely outcome of immunotherapy. The Symposium is followed by a cocktail dinatoire, where you can mingle and network.


Thursday November 29st, 2018

13:00 - 14:00 Registration & networking


Chairs: Thomas Vorup-Jensen & Georg Holländer

14:00 - 14:40 Bernard Malissen, CIML, Marseille, FR (Keynote): In the LEGO box of the TCR system ... from the list of parts to the assembly instructions!

14:40-15:10 Rikard Holmdahl, Karolinska Institutet, Stockholm, SE : How autoreactive lymphocytes learn about tissue specific antigens in cartilage

15:10 - 15:40 Søren Degn, Aarhus University, Aarhus, DK : Beyond antibodies – pleiotropic functions of B cells in autoimmune disease

15:40 - 16:10 Birgitte Ursø, LEO Pharma, Ballerup, DK : Translational drug discovery in biologics from early discovery to clinical testing

16:10 - 16:30 Coffee


Chairs: Hans-Jürgen Hoffmann & Poul Sørensen

16:30 – 17:00 Georg Holländer, University of Oxford, Oxford, UK : Deconstructing the thymus: Molecular insight into thymus development and function

17:00 - 17:30 Eva Pålsson-McDermott, Trinity College, Dublin, IRL : The role of metabolic reprogramming in macrophage effector function

17:30-18:00 Peter S. Andersen, ALK, Hørsholm, DK : Antibody repertoire development during sublingual allergy immunotherapy

18:00-18:30 Mo Shamji, Imperial College, London, UK : Peptide allergen immunotherapy: Ready for prime time

18:30 – 20:00 Networking and cocktail dinatoire



What are you looking for?
By using this website, you agree to the use of Cookies to give you the best user experience.Ok